Legend Biotech (LEGN) Shares Outstanding (Weighted Average) (2019 - 2025)
Historic Shares Outstanding (Weighted Average) for Legend Biotech (LEGN) over the last 6 years, with Q3 2025 value amounting to $720.0.
- Legend Biotech's Shares Outstanding (Weighted Average) rose 2857.14% to $720.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $720.0, marking a year-over-year increase of 2857.14%. This contributed to the annual value of $318.1 million for FY2022, which is 1291.45% up from last year.
- According to the latest figures from Q3 2025, Legend Biotech's Shares Outstanding (Weighted Average) is $720.0, which was up 2857.14% from $620.0 recorded in Q2 2025.
- In the past 5 years, Legend Biotech's Shares Outstanding (Weighted Average) registered a high of $318.1 million during Q4 2022, and its lowest value of $210.0 during Q2 2024.
- Its 4-year average for Shares Outstanding (Weighted Average) is $147.6 million, with a median of $138.6 million in 2021.
- As far as peak fluctuations go, Legend Biotech's Shares Outstanding (Weighted Average) plummeted by 9986.69% in 2021, and later soared by 11582417.96% in 2022.
- Quarter analysis of 4 years shows Legend Biotech's Shares Outstanding (Weighted Average) stood at $281.7 million in 2021, then increased by 12.91% to $318.1 million in 2022, then plummeted by 100.0% to $560.0 in 2024, then rose by 28.57% to $720.0 in 2025.
- Its last three reported values are $720.0 in Q3 2025, $620.0 for Q2 2025, and $560.0 during Q3 2024.